Author:
Bocklud Brooke E,Fakhre Waddih,Murphy Brennan,Maddox Kirsten,Ahmadzadeh Shahab,Viswanath Omar,Varrassi Giustino,Shekoohi Sahar,Kaye Alan D
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Rundle and his curve;Bartley GB;Arch Ophthalmol,2011
2. The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy;Bartalena L;Eur J Endocrinol,2021
3. Tepezza Approved for Thyroid Eye Disease Regardless of Disease Activity, Duration. (2023). Accessed. April 1, 2023: https://www.empr.com/home/news/tepezza-approved-for-thyroid-eye-disease-regardless-of-disease-activity-duration/.
4. Updates on the understanding and management of thyroid eye disease;Men CJ;Ther Adv Ophthalmol,2021
5. Thyroid eye disease;Rashad R;Life (Basel),2022